Hyperbaric Oxygen denied as not FDA-approved for this use by Aetna?

Aetna's specific coverage criteria for hyperbaric oxygen are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denied Hyperbaric Oxygen as "Not FDA-Approved" — and How to Appeal

This denial category is one of the most directly rebutted for hyperbaric oxygen therapy (HBOT), because HBOT devices and their uses for specific indications do carry FDA clearance — issued under the 510(k) process for hyperbaric chambers — and a list of recognized cleared indications exists. When Aetna issues a "not FDA-approved" denial for HBOT, the most common explanation is that: (1) the diagnosis code submitted corresponds to an off-label or non-cleared use, or (2) there was a billing or coding error that made the submission appear non-standard.

If your use falls within an FDA-cleared indication for HBOT, this denial is directly rebuttable with FDA's own documentation.

## Your Federal Appeal Rights

• Internal appeal: ERISA §503 and ACA §2719 require a full-and-fair internal review. Submit your appeal within the timeframe on your denial letter (typically 180 days).
• External review: ACA §2719 entitles most members to IRO review after exhausting internal appeals. You generally have four months (180 days) from the final adverse determination. For a "not FDA-approved" denial where FDA clearance demonstrably exists, external review is often highly favorable.
• Expedited review: Available if your condition is urgent. Aetna must respond to an expedited internal appeal within 72 hours.

## Documentation to Gather

1. FDA clearance documentation — obtain the official FDA device listing or 510(k) clearance summary that covers hyperbaric oxygen chambers for your specific indication. This is publicly available through the FDA's device database and is the single most powerful document in this appeal. 2. Diagnosis-to-indication alignment — a letter from your prescribing physician confirming that your documented diagnosis aligns precisely with an FDA-cleared indication for HBOT, citing the FDA document. 3. Procedure and diagnosis code review — ask your provider to verify that the CPT and ICD-10 codes submitted were accurate and reflect the FDA-cleared use. 4. Prescriber medical-necessity letter — a detailed letter explaining the diagnosis, clinical rationale, and how HBOT's cleared status applies to your case. 5. Aetna's clinical policy — request the exact policy version used in the denial to identify whether Aetna's policy is narrower than FDA clearance, which would itself be a basis for external review.

## Criteria-Mapping Structure

Organize your appeal around the FDA clearance first, then work backward to your diagnosis: "FDA clearance: [device cleared for indication X per attachment A] — Patient diagnosis: [ICD-10, confirmed in chart note dated (date)] — Alignment: as explained in prescriber letter dated [date], patient's diagnosis falls within FDA-cleared indication X." Attach the FDA source document directly to make the reviewer's job as simple as possible.